Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity

We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospective...

Full description

Saved in:
Bibliographic Details
Published inJournal of Korean medical science Vol. 29; no. 12; pp. 1665 - 1671
Main Authors Ahn, Jee Hwan, Kang, Byung Ju, Hong, Sun In, Lee, Jung Su, Lee, Jae Seung, Oh, Yeon-Mok, Lee, Sang-Do
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Academy of Medical Sciences 01.12.2014
대한의학회
Subjects
Online AccessGet full text
ISSN1011-8934
1598-6357
1598-6357
DOI10.3346/jkms.2014.29.12.1665

Cover

Abstract We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.
AbstractList We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P =0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P =0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P =0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.
We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.
We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterialhypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Dataon patients who were diagnosed with IPAH at Asan Medical Center between January 1994and March 2013 were retrospectively collected. Acute vasodilator testing was performedwith inhaled nitric oxide during diagnostic right heart catheterization. A positive acuteresponse was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥ 10 mmHgto an absolute level of mean PAP < 40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acuteresponse to acute vasodilator testing. Acute responders showed significantly lower peakvelocity of a tricuspid regurgitation jet on echocardiography (4.1 ± 0.3 m/s vs. 4.6 ± 0.6m/s; P = 0.01) and significantly lower mean PAP hemodynamically (47 ± 10 mmHg vs. 63 ± 17 mmHg; P = 0.003) than non-responders at baseline. The survival rate of acuteresponders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher thanthat of non-responders (85%, 71%, 55%, and 40%, respectively; P = 0.029). In conclusion,Korean IPAH patients with vasoreactivity showed better baseline hemodynamic featuresand survival than those without vasoreactivity. KCI Citation Count: 2
We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical characteristics and prognosis. Data on patients who were diagnosed with IPAH at Asan Medical Center between January 1994 and March 2013 were retrospectively collected. Acute vasodilator testing was performed with inhaled nitric oxide during diagnostic right heart catheterization. A positive acute response was defined as a reduction in mean pulmonary arterial pressure (PAP) ≥10 mmHg to an absolute level of mean PAP <40 mmHg without a decrease in cardiac output. Among a total of 60 IPAH patients included for analysis, 9 (15%) showed a positive acute response to acute vasodilator testing. Acute responders showed significantly lower peak velocity of a tricuspid regurgitation jet on echocardiography (4.1±0.3 m/s vs. 4.6±0.6 m/s; P=0.01) and significantly lower mean PAP hemodynamically (47±10 mmHg vs. 63±17 mmHg; P=0.003) than non-responders at baseline. The survival rate of acute responders was 88% at 1, 3, 5, and 10 yr, respectively, which was significantly higher than that of non-responders (85%, 71%, 55%, and 40%, respectively; P=0.029). In conclusion, Korean IPAH patients with vasoreactivity showed better baseline hemodynamic features and survival than those without vasoreactivity.
Author Ahn, Jee Hwan
Lee, Jae Seung
Lee, Sang-Do
Lee, Jung Su
Oh, Yeon-Mok
Hong, Sun In
Kang, Byung Ju
AuthorAffiliation 3 Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
2 Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
1 Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
AuthorAffiliation_xml – name: 1 Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– name: 2 Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– name: 3 Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Author_xml – sequence: 1
  givenname: Jee Hwan
  orcidid: 0000-0001-6653-998X
  surname: Ahn
  fullname: Ahn, Jee Hwan
  organization: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– sequence: 2
  givenname: Byung Ju
  orcidid: 0000-0002-1396-7398
  surname: Kang
  fullname: Kang, Byung Ju
  organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– sequence: 3
  givenname: Sun In
  orcidid: 0000-0003-2575-2084
  surname: Hong
  fullname: Hong, Sun In
  organization: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– sequence: 4
  givenname: Jung Su
  orcidid: 0000-0001-5644-0150
  surname: Lee
  fullname: Lee, Jung Su
  organization: Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– sequence: 5
  givenname: Jae Seung
  orcidid: 0000-0003-4130-1486
  surname: Lee
  fullname: Lee, Jae Seung
  organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– sequence: 6
  givenname: Yeon-Mok
  orcidid: 0000-0003-0116-4683
  surname: Oh
  fullname: Oh, Yeon-Mok
  organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
– sequence: 7
  givenname: Sang-Do
  orcidid: 0000-0001-8189-4509
  surname: Lee
  fullname: Lee, Sang-Do
  organization: Department of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Center for Pulmonary Hypertension and Venous Thromboembolism, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25469067$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001935478$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9Uklv1DAUtlARXeAfIOQjl4R4TcwBaRgBHVGJCgpXy3Fsxp3EDnYy0og_j9OhbAdOfsu32M_vHJz44A0AT1FVEkL5i9vdkEpcIVpiUSJcIs7ZA3CGmGgKTlh9kuMKoaIRhJ6C85RuqwozhskjcIoZ5aLi9Rn4vu6dd1r1cL1VUenJRJcmpxNUvoOf5rh3-9wMFr4P0SgPN50Lo5q2TsPruR-CV_EAV3HhZdzlYTQ59skFD6_V5IyfEnytkulgrnxRaVHRk9u76fAYPLSqT-bJz_MCfH775mZ9WVx9eLdZr64KTSmaiprilthOsJwyLWhNqG5sLnTMKKOIVpzVLaPEWtQaYZVVOme0Fhq1tqnIBXh-1PXRyp12Mih3d34Nchfl6uPNRrIa55ll6KsjdJzbwXQ6Xz-qXo7RDfmdd8S_O95ts8xeUkwb1jS_vcYYvs0mTXJwSZu-V96EOUnEsRCcccQz9NmfXr9M7j8nA14eATqGlKKxUrspzzQs1q6XqJLLJshlE-SyCRILibBcNiGT6T_ke_3_0n4A_1i8qg
CitedBy_id crossref_primary_10_3346_jkms_2015_30_10_1429
crossref_primary_10_3904_kjim_2019_185
Cites_doi 10.1016/j.jacc.2009.01.004
10.7326/0003-4819-107-2-216
10.1016/S0735-1097(03)00463-7
10.1016/j.jacc.2009.04.012
10.3346/jkms.2013.28.8.1200
10.1016/j.jacc.2009.04.017
10.1183/09031936.98.12020265
10.1164/rccm.200510-1668OC
10.1016/j.jacc.2013.10.029
10.1378/chest.09-1140
10.1093/eurheartj/ehp297
10.1183/09031936.00169608
10.3346/jkms.2012.27.8.901
10.1378/chest.11-3060
10.1164/ajrccm/140.6.1623
10.1056/NEJM199207093270203
10.1378/chest.111.1.36
10.2169/internalmedicine.51.8162
10.1161/CIRCULATIONAHA.104.488486
10.1378/chest.06-2913
ContentType Journal Article
Copyright 2014 The Korean Academy of Medical Sciences. 2014
Copyright_xml – notice: 2014 The Korean Academy of Medical Sciences. 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ACYCR
DOI 10.3346/jkms.2014.29.12.1665
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1598-6357
EndPage 1671
ExternalDocumentID oai_kci_go_kr_ARTI_572357
PMC4248588
25469067
10_3346_jkms_2014_29_12_1665
Genre Journal Article
GeographicLocations Republic of Korea
GeographicLocations_xml – name: Republic of Korea
GroupedDBID ---
29K
2WC
3O-
5-W
53G
5GY
8JR
8XY
9ZL
AAYXX
ADBBV
ADRAZ
AENEX
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
CS3
D-I
DIK
DU5
E3Z
EBS
EF.
EJD
F5P
FRP
GROUPED_DOAJ
GX1
HYE
KQ8
M48
O5R
O5S
OK1
OVT
PGMZT
RNS
RPM
TR2
W2D
XSB
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
08R
ACYCR
M~E
ID FETCH-LOGICAL-c441t-742b3fd95c445c94734c8ffd9d5eaea3ca657b543ff1be9fafac543479c1bf803
IEDL.DBID M48
ISSN 1011-8934
1598-6357
IngestDate Tue Nov 21 21:40:42 EST 2023
Thu Aug 21 14:04:37 EDT 2025
Fri Jul 11 01:22:50 EDT 2025
Thu Apr 03 07:01:06 EDT 2025
Tue Jul 01 01:44:55 EDT 2025
Thu Apr 24 23:07:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Calcium Channel Blockers
Vasodilator Agents
Hypertension, Pulmonary
Survival Rate
Language English
License http://creativecommons.org/licenses/by-nc/4.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c441t-742b3fd95c445c94734c8ffd9d5eaea3ca657b543ff1be9fafac543479c1bf803
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Jee Hwan Ahn and Byung Ju Kang contributed equally to this work.
G704-000345.2014.12.12.020
ORCID 0000-0001-6653-998X
0000-0002-1396-7398
0000-0003-0116-4683
0000-0001-5644-0150
0000-0003-4130-1486
0000-0001-8189-4509
0000-0003-2575-2084
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3346/jkms.2014.29.12.1665
PMID 25469067
PQID 1629965616
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_572357
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4248588
proquest_miscellaneous_1629965616
pubmed_primary_25469067
crossref_citationtrail_10_3346_jkms_2014_29_12_1665
crossref_primary_10_3346_jkms_2014_29_12_1665
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-12-01
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-12-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of Korean medical science
PublicationTitleAlternate J Korean Med Sci
PublicationYear 2014
Publisher The Korean Academy of Medical Sciences
대한의학회
Publisher_xml – name: The Korean Academy of Medical Sciences
– name: 대한의학회
References Humbert (10.3346/jkms.2014.29.12.1665_ref8) 2006; 173
Sitbon (10.3346/jkms.2014.29.12.1665_ref12) 1998; 12
McLaughlin (10.3346/jkms.2014.29.12.1665_ref1) 2009; 53
Barst (10.3346/jkms.2014.29.12.1665_ref21) 2009; 54
Jing (10.3346/jkms.2014.29.12.1665_ref15) 2009; 33
Rich (10.3346/jkms.2014.29.12.1665_ref4) 1992; 327
Simonneau (10.3346/jkms.2014.29.12.1665_ref2) 2009; 54
Jing (10.3346/jkms.2014.29.12.1665_ref13) 2007; 132
Sakao (10.3346/jkms.2014.29.12.1665_ref14) 2012; 51
Park (10.3346/jkms.2014.29.12.1665_ref20) 2013; 28
Sitbon (10.3346/jkms.2014.29.12.1665_ref5) 2005; 111
Galiè (10.3346/jkms.2014.29.12.1665_ref6) 2009; 30
Simonneau (10.3346/jkms.2014.29.12.1665_ref11) 2013; 62
McLaughlin (10.3346/jkms.2014.29.12.1665_ref18) 2013; 143
Rich (10.3346/jkms.2014.29.12.1665_ref3) 1987; 107
Barst (10.3346/jkms.2014.29.12.1665_ref19) 2003; 41
Tueller (10.3346/jkms.2014.29.12.1665_ref9) 2008; 138
Weir (10.3346/jkms.2014.29.12.1665_ref7) 1989; 140
Murata (10.3346/jkms.2014.29.12.1665_ref10) 1997; 111
Badesch (10.3346/jkms.2014.29.12.1665_ref16) 2010; 137
Joo (10.3346/jkms.2014.29.12.1665_ref17) 2012; 27
9727772 - Eur Respir J. 1998 Aug;12(2):265-70
22876057 - J Korean Med Sci. 2012 Aug;27(8):901-6
19389575 - J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619
23037462 - Intern Med. 2012;51(19):2721-6
17400671 - Chest. 2007 Aug;132(2):373-9
19213781 - Eur Respir J. 2009 Jun;33(6):1354-60
19555861 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-84
23960448 - J Korean Med Sci. 2013 Aug;28(8):1200-6
8995990 - Chest. 1997 Jan;111(1):36-43
19555858 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54
3605900 - Ann Intern Med. 1987 Aug;107(2):216-23
12821234 - J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25
15939821 - Circulation. 2005 Jun 14;111(23):3105-11
22910999 - Chest. 2013 Feb 1;143(2):324-32
1603139 - N Engl J Med. 1992 Jul 9;327(2):76-81
19837821 - Chest. 2010 Feb;137(2):376-87
24355639 - J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41
19713419 - Eur Heart J. 2009 Oct;30(20):2493-537
18587690 - Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84
16456139 - Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30
2690706 - Am Rev Respir Dis. 1989 Dec;140(6):1623-30
References_xml – volume: 53
  start-page: 1573
  year: 2009
  ident: 10.3346/jkms.2014.29.12.1665_ref1
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.01.004
– volume: 107
  start-page: 216
  year: 1987
  ident: 10.3346/jkms.2014.29.12.1665_ref3
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-107-2-216
– volume: 41
  start-page: 2119
  year: 2003
  ident: 10.3346/jkms.2014.29.12.1665_ref19
  publication-title: J Am Coll Cardiol
  doi: 10.1016/S0735-1097(03)00463-7
– volume: 54
  start-page: S43
  year: 2009
  ident: 10.3346/jkms.2014.29.12.1665_ref2
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.04.012
– volume: 28
  start-page: 1200
  year: 2013
  ident: 10.3346/jkms.2014.29.12.1665_ref20
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2013.28.8.1200
– volume: 54
  start-page: S78
  year: 2009
  ident: 10.3346/jkms.2014.29.12.1665_ref21
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2009.04.017
– volume: 12
  start-page: 265
  year: 1998
  ident: 10.3346/jkms.2014.29.12.1665_ref12
  publication-title: Eur Respir J
  doi: 10.1183/09031936.98.12020265
– volume: 173
  start-page: 1023
  year: 2006
  ident: 10.3346/jkms.2014.29.12.1665_ref8
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200510-1668OC
– volume: 138
  start-page: 379
  year: 2008
  ident: 10.3346/jkms.2014.29.12.1665_ref9
  publication-title: Swiss Med Wkly
– volume: 62
  start-page: D34
  year: 2013
  ident: 10.3346/jkms.2014.29.12.1665_ref11
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2013.10.029
– volume: 137
  start-page: 376
  year: 2010
  ident: 10.3346/jkms.2014.29.12.1665_ref16
  publication-title: Chest
  doi: 10.1378/chest.09-1140
– volume: 30
  start-page: 2493
  year: 2009
  ident: 10.3346/jkms.2014.29.12.1665_ref6
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehp297
– volume: 33
  start-page: 1354
  year: 2009
  ident: 10.3346/jkms.2014.29.12.1665_ref15
  publication-title: Eur Respir J
  doi: 10.1183/09031936.00169608
– volume: 27
  start-page: 901
  year: 2012
  ident: 10.3346/jkms.2014.29.12.1665_ref17
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2012.27.8.901
– volume: 143
  start-page: 324
  year: 2013
  ident: 10.3346/jkms.2014.29.12.1665_ref18
  publication-title: Chest
  doi: 10.1378/chest.11-3060
– volume: 140
  start-page: 1623
  year: 1989
  ident: 10.3346/jkms.2014.29.12.1665_ref7
  publication-title: Am Rev Respir Dis
  doi: 10.1164/ajrccm/140.6.1623
– volume: 327
  start-page: 76
  year: 1992
  ident: 10.3346/jkms.2014.29.12.1665_ref4
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199207093270203
– volume: 111
  start-page: 36
  year: 1997
  ident: 10.3346/jkms.2014.29.12.1665_ref10
  publication-title: Chest
  doi: 10.1378/chest.111.1.36
– volume: 51
  start-page: 2721
  year: 2012
  ident: 10.3346/jkms.2014.29.12.1665_ref14
  publication-title: Intern Med
  doi: 10.2169/internalmedicine.51.8162
– volume: 111
  start-page: 3105
  year: 2005
  ident: 10.3346/jkms.2014.29.12.1665_ref5
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.104.488486
– volume: 132
  start-page: 373
  year: 2007
  ident: 10.3346/jkms.2014.29.12.1665_ref13
  publication-title: Chest
  doi: 10.1378/chest.06-2913
– reference: 3605900 - Ann Intern Med. 1987 Aug;107(2):216-23
– reference: 17400671 - Chest. 2007 Aug;132(2):373-9
– reference: 9727772 - Eur Respir J. 1998 Aug;12(2):265-70
– reference: 22910999 - Chest. 2013 Feb 1;143(2):324-32
– reference: 2690706 - Am Rev Respir Dis. 1989 Dec;140(6):1623-30
– reference: 1603139 - N Engl J Med. 1992 Jul 9;327(2):76-81
– reference: 24355639 - J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D34-41
– reference: 18587690 - Swiss Med Wkly. 2008 Jun 28;138(25-26):379-84
– reference: 19213781 - Eur Respir J. 2009 Jun;33(6):1354-60
– reference: 19555861 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S78-84
– reference: 19555858 - J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-54
– reference: 19713419 - Eur Heart J. 2009 Oct;30(20):2493-537
– reference: 22876057 - J Korean Med Sci. 2012 Aug;27(8):901-6
– reference: 8995990 - Chest. 1997 Jan;111(1):36-43
– reference: 15939821 - Circulation. 2005 Jun 14;111(23):3105-11
– reference: 23960448 - J Korean Med Sci. 2013 Aug;28(8):1200-6
– reference: 16456139 - Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30
– reference: 19837821 - Chest. 2010 Feb;137(2):376-87
– reference: 12821234 - J Am Coll Cardiol. 2003 Jun 18;41(12):2119-25
– reference: 19389575 - J Am Coll Cardiol. 2009 Apr 28;53(17):1573-619
– reference: 23037462 - Intern Med. 2012;51(19):2721-6
SSID ssj0025523
Score 2.027469
Snippet We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterial hypertension (IPAH) in Korea and to show their clinical...
We aimed to identify a vasoreactive subset of patients with idiopathic pulmonary arterialhypertension (IPAH) in Korea and to show their clinical...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1665
SubjectTerms Adolescent
Adult
Aged
Female
Humans
Hypertension, Pulmonary - diagnosis
Hypertension, Pulmonary - mortality
Hypertension, Pulmonary - physiopathology
Male
Middle Aged
Original
Prevalence
Prognosis
Reproducibility of Results
Republic of Korea - epidemiology
Risk Factors
Sensitivity and Specificity
Survival Rate
Vascular Resistance - drug effects
Vasodilator Agents
Young Adult
의학일반
Title Clinical Characteristics and Survival of Korean Idiopathic Pulmonary Arterial Hypertension Patients Based on Vasoreactivity
URI https://www.ncbi.nlm.nih.gov/pubmed/25469067
https://www.proquest.com/docview/1629965616
https://pubmed.ncbi.nlm.nih.gov/PMC4248588
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001935478
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Korean Medical Science, 2014, 12(12), 195, pp.1665-1671
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lj9MwELZ2FwlxQbwpj8pIXLOqYzuxDwjBilXLqmglKNqb5fixVC0OpK3Eij_PTJJWFC2CU5TUmbiZSeb7YvsbQl5GWwJfiz5TWvJMlKOQacClGYuQf1zllXC4UHj6oRjPxPsLeXFAtjVb-xu4upbaYT2pWbM8_vH96jU88K-QcXIcoVx8ReFtJo5zjd_2WFHIQ3IDclOBdGwqduMKgJ_zbso9Y9A7LrrFdH-1spesDlMTr8Ohf06n_C0_nd4ht3tgSd90kXCXHIR0j9yc9kPn98nPXgF0SU_2NZqpTZ5-3MArA4KO1pGe1QAkE534ed3WK3b0fLOEaLXNFZpvQ5aOgb827ez3OtHzTpx1Rd9CTvQUjny2K7TiutoUD8js9N2nk3HWV17IHMCjdQZ8ueLRawm70mlRcuFUhANeBhssd7aQZSUFj5FVQUcbrcM1qqV2rIpqxB-So1Sn8JhQWSEJwhWtABbkyCqvHJhQMfi88nkxIHx7i43rZcmxOsbSAD1Bxxh0jEHHmFwblht0zIBku7O-dbIc_2j_ArxnFm5uUE8bt5e1WTQGWMPEyBJFf6DN1rcGnjEcOLEp1JsVWICkDcCXQW8fdb7eXRXrCWhI-QNS7kXBrgFeb_-XNP_S6ngLlJNT6sl_9O0puYX_qJtH84wcrZtNeA5oaF0NgQdMzobtt4RhG-y_AFalDAM
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Characteristics+and+Survival+of+Korean+Idiopathic+Pulmonary+Arterial+Hypertension+Patients+Based+on+Vasoreactivity&rft.jtitle=Journal+of+Korean+medical+science&rft.au=%EC%95%88%EC%A7%80%ED%99%98&rft.au=%EA%B0%95%EB%B3%91%EC%A3%BC&rft.au=%ED%99%8D%EC%84%A0%EC%9D%B8&rft.au=%EC%9D%B4%EC%A0%95%EC%88%98&rft.date=2014-12-01&rft.pub=%EB%8C%80%ED%95%9C%EC%9D%98%ED%95%99%ED%9A%8C&rft.issn=1011-8934&rft.eissn=1598-6357&rft.spage=1665&rft.epage=1671&rft_id=info:doi/10.3346%2Fjkms.2014.29.12.1665&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_572357
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1011-8934&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1011-8934&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1011-8934&client=summon